Diagnostic Value of Serum and Urine Endocan Levels in Nonmuscle Invasive Bladder Cancer: A Prospective Comparative Study

<table class="table-group" id="tab4"><tr><td><table class="table"><tr><td class="thead-hr" colspan="6"><hr/></td></tr><tr class="thead"><td class="align_left"> </td><td class="align_center">Cut-off value</td><td class="align_center">Sensitivity-specificity (%)</td><td class="align_center">AUC</td><td class="align_center">95% CI</td><td class="align_center"><i>p</i> value</td></tr><tr><td class="thead-hr" colspan="6"><hr/></td></tr><tr><td class="align_left">Urine endocan (mg/dl)</td><td class="align_center">903</td><td class="align_center">(50.0–78.6)</td><td class="align_center">0.735</td><td class="align_center">0.584–0.886</td><td class="align_center">0.007</td></tr><tr class="table-tr"><td colspan="6"><hr class="tbody-hr"/></td></tr></table></td></tr><tr class="table-fn"><td><div>ROC, receiver operating characteristic; AUC, area under the ROC curve; CI, confidence interval.<br/></div></td></tr></table>

<div>Receiver operating characteristic (ROC) analysis of urinary endocan level predictive value in predicting T1 disease.</div>

International Journal of Clinical Practice

tab4

Table 4

Table 4: Diagnostic Value of Serum and Urine Endocan Levels in Nonmuscle Invasive Bladder Cancer: A Prospective Comparative Study 